Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOCARTIS-GROUP-NV-22033639/news/Biocartis-and-Amgen-Sign-Companion-Diagnostic-Agreement-for-Idylla-RAS-Biomarker-Tests-25609065/?utm_source=whatsapp&utm_medium=social&utm_campaign=share